This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998 Dec;28(12):1095-128.

doi: 10.1080/004982598238859.

Human cytochrome P450s: selectivity and measurement in vivo

D A Smith¹, S M Abel, R Hyland, B C Jones

Affiliations

PMID: 9890156
DOI: 10.1080/004982598238859

Review

Human cytochrome P450s: selectivity and measurement in vivo

D A Smith et al. Xenobiotica. 1998 Dec.

. 1998 Dec;28(12):1095-128.

doi: 10.1080/004982598238859.

Authors

D A Smith¹, S M Abel, R Hyland, B C Jones

Affiliation

¹ Department of Drug Metabolism, Pfizer Central Research, Sandwich, UK.

PMID: 9890156
DOI: 10.1080/004982598238859

No abstract available

PubMed Disclaimer

Similar articles

Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X, Wang JS, Backman JT, Kivistö KT, Neuvonen PJ. Wen X, et al. Drug Metab Dispos. 2001 Nov;29(11):1359-61. Drug Metab Dispos. 2001. PMID: 11602509
Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
Murray S, Odupitan AO, Murray BP, Boobis AR, Edwards RJ. Murray S, et al. Xenobiotica. 2001 Mar;31(3):135-51. doi: 10.1080/00498250110043292. Xenobiotica. 2001. PMID: 11465391
Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
Frye RF, Branch RA. Frye RF, et al. Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x. Br J Clin Pharmacol. 2002. PMID: 11851639 Free PMC article.
Pharmacogenetics and pharmacogenomics.
Leeder JS. Leeder JS. Pediatr Clin North Am. 2001 Jun;48(3):765-81. doi: 10.1016/s0031-3955(05)70338-2. Pediatr Clin North Am. 2001. PMID: 11411304 Review.
Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase.
Anderson GD. Anderson GD. J Gend Specif Med. 2002 Jan-Feb;5(1):25-33. J Gend Specif Med. 2002. PMID: 11859684 Review.

See all similar articles

Cited by

Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies.
Bonnabry P, Sievering J, Leemann T, Dayer P. Bonnabry P, et al. Clin Pharmacokinet. 2001;40(9):631-40. doi: 10.2165/00003088-200140090-00001. Clin Pharmacokinet. 2001. PMID: 11605713
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
Cotreau MM, von Moltke LL, Greenblatt DJ. Cotreau MM, et al. Clin Pharmacokinet. 2005;44(1):33-60. doi: 10.2165/00003088-200544010-00002. Clin Pharmacokinet. 2005. PMID: 15634031 Review.
Pharmacogenetics of antidepressants.
Crisafulli C, Fabbri C, Porcelli S, Drago A, Spina E, De Ronchi D, Serretti A. Crisafulli C, et al. Front Pharmacol. 2011 Feb 16;2:6. doi: 10.3389/fphar.2011.00006. eCollection 2011. Front Pharmacol. 2011. PMID: 21687501 Free PMC article.
Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
Narasimhan S, Lohoff FW. Narasimhan S, et al. Pharmacogenomics. 2012 Mar;13(4):441-64. doi: 10.2217/pgs.12.1. Pharmacogenomics. 2012. PMID: 22380000 Free PMC article. Review.
Hyperforin in St. John's wort drug interactions.
Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V. Madabushi R, et al. Eur J Clin Pharmacol. 2006 Mar;62(3):225-33. doi: 10.1007/s00228-006-0096-0. Epub 2006 Feb 14. Eur J Clin Pharmacol. 2006. PMID: 16477470 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon